வார்ப்புரு:Chromalveolate antiparasitics
{{navbox | listclass = hlist
 | name  = Chromalveolate antiparasitics
 | title = [[Antiparasitic]]s&amp;nbsp;– [[antiprotozoal agent]]s&amp;nbsp;– [[Chromalveolate]] antiparasitics ([[ATC code P01|P01]]) 
 | state = {{{state&lt;includeonly&gt;|autocollapse&lt;/includeonly&gt;}}}
 | groupstyle = background:PowderBlue;
 | belowstyle = background:#ADFF2F;  
 
 |group1  =[[Alveolate|Alveo-&lt;BR&gt;late]]
 |list1   = {{navbox subgroup
 | groupstyle = background:PowderBlue;
 
 | group1 =[[Apicomplexa|Apicom-&lt;BR&gt;plexa]]
 | list1  = {{navbox subgroup
 | groupstyle = background:PowderBlue; 
 
 | group1 =[[Conoidasida]]/&lt;BR&gt;([[Coccidiostat]]s)
 | list1  = {{navbox subgroup
 | groupstyle = background:PowderBlue; 
 
 | group1 =[[Cryptosporidiosis#Treatment|Cryptosporidiosis]]
 | list1  = ''[[thiazole]]'' ([[Nitazoxanide]])
 
 | group2 =[[Isosporiasis#Treatment|Isosporiasis]]
 | list2  = [[Co-trimoxazole]]&lt;sup&gt;#&lt;/sup&gt;
 
 | group3 =[[Toxoplasmosis#Treatment|Toxoplasmosis]]
 | list3  = [[Pyrimethamine]] • [[Sulfadiazine]]
 
 }}
 
 
 | group2 =[[Aconoidasida]]
 | list2  = {{navbox subgroup
 | groupstyle = background:PowderBlue; 
 
 | group1 =[[Antimalarial drug|Malaria]]
 | list1  = {{navbox subgroup
 | groupstyle = background:PowderBlue;
 
 | group1 =Individual &lt;BR&gt;agents
 | list1  = {{navbox subgroup
 | groupstyle = background:PowderBlue;
 
 | group1 =[[Hemozoin#Inhibitors|Hemozoin&lt;BR&gt;inhibitors]]
 | list1  = {{navbox subgroup
 | groupstyle = background:PowderBlue; 
 
 | group1 = [[Aminoquinoline]]s
 | list1  = (4-): [[Amodiaquine]]&lt;sup&gt;#&lt;/sup&gt; • [[Chloroquine]]&lt;sup&gt;#&lt;/sup&gt; &lt;BR&gt; (8-): [[Primaquine]]&lt;sup&gt;#&lt;/sup&gt; • [[Pamaquine]]
 
 | group2 = [[4-Methanolquinoline|4-methanolquinoline]]s
 | list2  = [[Mefloquine]]&lt;sup&gt;#&lt;/sup&gt;• [[Quinine]]&lt;sup&gt;#&lt;/sup&gt; • [[Quinidine]]
 
 | group3 = Other
 | list3  = [[Lumefantrine]] (combined with artemether as [[Coartem]])&lt;BR&gt;[[Halofantrine]]
 
 
 }} 
 
 | group2 = [[Antifolate]]s
 | list2  = {{navbox subgroup
 | groupstyle = background:PowderBlue; 
 
 | group1 = [[Dihydrofolate reductase inhibitor|DRI]]s
 | list1  = ''[[2,4-Diaminopyrimidine]]s'' ([[Pyrimethamine]]) &lt;BR&gt;''[[biguanide]]s'' ([[Proguanil]]&lt;sup&gt;#&lt;/sup&gt; • [[Chlorproguanil]]) 
 
 | group2 = [[Dihydropteroate synthetase inhibitor|DSI]]s
 | list2  = [[Sulfadoxine]] • Sulfamethoxypyrazine
 
 | group3 = Combination
 | list3  = Fansidar&lt;sup&gt;#&lt;/sup&gt; (pyrimethamine-sulfadoxine) 
 
 }}
 
 | group3 = [[Sesquiterpene lactones|Sesquiterpene&lt;BR&gt;lactones]]
 | list3  =  [[Artemether]]&lt;sup&gt;#&lt;/sup&gt; • [[Artesunate]]&lt;sup&gt;#&lt;/sup&gt;• [[Dihydroartemisinin]] •&lt;BR&gt;  [[Artemotil|Arteether/Artemotil]] • [[Artemisinin]] 
 
 | group4 = Other
 | list4  =  [[Atovaquone]] (combined with proguanil as Malarone) &lt;BR&gt; [[டெட்ராசைக்ளின்]] • [[Doxycycline]]&lt;sup&gt;#&lt;/sup&gt;&lt;BR&gt;Clindamycin
 
 }}
 | group2 = Combi-&lt;BR&gt;nations
 | list2  = {{navbox subgroup
 | groupstyle = background:PowderBlue;
 
 | group1 = Fixed-dose (coformulated)  [[Artemisinin|ACTs]]
 | list1  = [[Coartem]]&lt;sup&gt;#&lt;/sup&gt;  • [[ASAQ]] (Coarsucam) •  ASMQ •&lt;BR&gt;Duo-Cotecxin (Artekin) 
 
 | group3 = Combination therapies &lt;BR&gt;(not co-formulated)
 | list3  = Artequin • Ariplus • Co-Arinate • [[Chlorproguanil hydrochloride-dapsone-artesunate|CDA]]
 }}
 
 }}
 
 | group2 = [[Babesiosis#Treatment|Babesiosis]]
 | list2  = [[கிளின்டாமைசின்]]
 
 
 }}
 
 
 
 }}
 
 | group2 = [[Ciliophora|Cilio-&lt;BR&gt;phora]]
 | list2  = [[Balantidiasis#Treatment|Balantidiasis]]: [[டெட்ராசைக்ளின்]]
 
 }} 
 
 |group2  = [[Heterokont|Hetero-&lt;BR&gt;kont]]
 |list2   = [[Blastocystosis#Treatment|Blastocystosis]]: [[மெட்ரோனிடசோல்]]
 
 | below = {{PharmNavFootnote}}&lt;BR&gt;{{CEA navs}}
 
 }}&lt;noinclude&gt;
 
 [[Category:Drug templates|{{PAGENAME}}]]